COMPANY PROFILE / #3043
AMPLY Discovery
Belfast, United KingdomVenture Capital-Backed
OVERVIEW
Developer of a drug discovery studio designed to discover new cures for cancer, metabolic disease, and infectious diseases through artificial intelligence (AI) and synthetic biology. The company uses machine learning and synthetic biology, which digitizes life's natural diversity and identifies putative drug candidates based on function, enabling research entities to find new therapeutic molecules for hard-to-treat diseases.
已融资5.70
最新估值42.50
员工数6
成立年份2021
公司概况
- Companies
- AMPLY Discovery
- Description
- Developer of a drug discovery studio designed to discover new cures for cancer, metabolic disease, and infectious diseases through artificial intelligence (AI) and synthetic biology. The company uses machine learning and synthetic biology, which digitizes life's natural diversity and identifies putative drug candidates based on function, enabling research entities to find new therapeutic molecules for hard-to-treat diseases.
- Website
- www.amplydiscovery.com
- HQ Location
- Belfast, United Kingdom
- Year Founded
- 2021
- Keywords
- acute myeloid leukemia, ai drug discovery, animal biotechnology, antimicrobial resistance, cancer biological therapies, drug discovery platform, drug discovery tech, metabolic disease therapeutics
- Competitors
- —
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 5.70
- First Financing Date
- 01-Jan-2021
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- 08-Jan-2026
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- 2.34
- Last Financing Valuation
- 42.50
- Last Financing Status
- Completed
- Last Known Valuation
- 42.50
- Last Known Valuation Date
- 08-Jan-2026
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 63.14
- Valuation Estimate Growth Rate
- 48.57%
- Active Investors
- British Business Bank, Clarendon Fund Managers, College Green Ventures, EIT Food, Halo Business Angel Network, Helix Way Partnership, Innovate UK, Invest Northern Ireland, Keeps Biopharma, QUBIS, Queen's University Belfast, Sapphire Capital Partners, Techstars, Twin Path Ventures, Venture Science
- # Active Investors
- 15
- Acquirers
- —
团队与联系人
- Employees
- 6
- Employee Growth %
- 0.00%
- Employee History
- 2026: 6, 2025: 6, 2024: 5, 2023: 5, 2022: 4, 2021: 4
- Primary Contact
- Dermot Tierney
- Primary Contact Title
- Co-Founder, Chief Operating Officer, Chief Financial Officer, Chief Commercial Officer & Director
- Primary Contact Email
- dermot.tierney@amplydiscovery.com
- Primary Contact Phone
- —
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- —
- Growth Rate % Change
- —
- Growth Rate Percentile
- —
- Size Multiple
- —
- Size Multiple % Change
- —
- Size Multiple Change
- —
- Size Multiple Percentile
- —
- Majestic Referring Domains
- —
- SimilarWeb Unique Visitors
- —
- SimilarWeb Unique Visitors Change
- —
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- —
- Success Probability Over Time – 3 Year
- —
- Success Probability Over Time – 5 Year
- —
记录来源：public.companies · 原始序号 #3043 · 所有字段均按数据库原值展示。